Congress ticker disclosure profile

As of July 18 at 5:02 AM EDT

Public STOCK Act rows mentioning

REPYY

A factual page for public Congressional disclosures that reference REPYY. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.

90d rows

0

Feed lifetime

18

Member filers

2

Disclosed ranges

$345K

Latest source-stamped receipts

Latest trade Nov 13, 2020

DateMemberActionAmountFiledReceipt
Nov 13, 2020Greg GianforteSell$15,001 to $50,000Feb 14, 2020Open card
Mar 18, 2020Greg GianforteBuy$1,001 to $15,000Feb 14, 2020Open card
Dec 10, 2018Thomas MacarthurSell$50,001 to $100,000Date not disclosedOpen card
Nov 19, 2018Greg GianforteSell$1,001 to $15,000Date not disclosedOpen card
Nov 12, 2018Thomas MacarthurBuyReceipt pending ingestionDate not disclosedReceipt pending ingestion
Nov 12, 2018Thomas MacarthurBuy$15,001 to $50,000Date not disclosedOpen card
Oct 5, 2018Thomas MacarthurBuyReceipt pending ingestionDate not disclosedReceipt pending ingestion
Oct 5, 2018Thomas MacarthurBuy$15,001 to $50,000Date not disclosedOpen card
Sep 27, 2018Thomas MacarthurBuyReceipt pending ingestionDate not disclosedReceipt pending ingestion
Sep 27, 2018Thomas MacarthurBuy$15,001 to $50,000Date not disclosedOpen card
May 19, 2015Thomas MacarthurSellReceipt pending ingestionJun 7, 2015Receipt pending ingestion
May 19, 2015Thomas MacarthurSell$50,001 to $100,000Jun 7, 2015Open card
Jan 27, 2015Thomas MacarthurSellReceipt pending ingestionMar 5, 2015Receipt pending ingestion
Jan 27, 2015Thomas MacarthurSell$1,001 to $15,000Mar 5, 2015Open card
Jan 26, 2015Thomas MacarthurBuyReceipt pending ingestionMar 5, 2015Receipt pending ingestion
Jan 26, 2015Thomas MacarthurBuy$15,001 to $50,000Mar 5, 2015Open card
Jan 12, 2015Thomas MacarthurBuyReceipt pending ingestionMar 5, 2015Receipt pending ingestion
Jan 12, 2015Thomas MacarthurBuy$1,001 to $15,000Mar 5, 2015Open card

Source creed

This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 11 of 18 filed rows include disclosed amount ranges (61%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.

Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.